TEF and hepatocellular carcinoma: These results suggested that the Treg/Tef ratio was preferentially upregulated in relapsed HCC patients and that a high Treg/Tef level correlated with poor HCC prognosis, which indicated that Treg/Tef could be a prognostic biomarker for primary HCC patients.